Epicentre Research Technologies Bangalore Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2017
- Revenue %
(FY 2017)
- Profit 23.60%
(FY 2017)
- Ebitda 40.76%
(FY 2017)
- Net Worth -41.62%
(FY 2017)
- Total Assets -0.06%
(FY 2017)
About Epicentre Research Technologies Bangalore
The Company is engaged in the Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gouri Datta and Abhay Jain serve as directors at the Company.
- CIN/LLPIN
U73100KA2005PTC037826
- Company No.
037826
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2005
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Epicentre Research Technologies Bangalore?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gouri Datta  | Additional Director | 08-Jan-2021 | Current |
| Abhay Jain | Additional Director | 08-Jan-2021 | Current |
Financial Performance and Corporate Structure Insights of Epicentre Research Technologies Bangalore.
Epicentre Research Technologies Bangalore Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 23.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 41.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Epicentre Research Technologies Bangalore?
In 2017, Epicentre Research Technologies Bangalore had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quantify Research And Development Private Limited
Active
3 years 3 months Gouri Datta and Abhay Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Epicentre Research Technologies Bangalore?
Unlock and access historical data on people associated with Epicentre Research Technologies Bangalore, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Epicentre Research Technologies Bangalore, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epicentre Research Technologies Bangalore's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
